Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Tailored Support for Type 2 Diabetes Patients With an Acute Coronary Event After Discharge From Hospital [NA]
A completed clinical trial evaluating tailored post-discharge support for people with type 2 diabetes after an acute coronary event.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Russia
This clinical trial update reports long-term follow-up data on antithrombotic management patterns in acute coronary syndrome patients in Rus…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions [Phase 1]
Phase 1 trial assessing early administration of rosuvastatin in acute coronary syndrome to target platelet-leukocyte interactions.
-
FDA approval · 2014-06-23FDA Approved: ENOXAPARIN SODIUM — Original Application (Italfarmaco SpA)
FDA approved the original application for ENOXAPARIN SODIUM (enoxaparin sodium) submitted by Italfarmaco SpA under an ANDA. The approval con…
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
This report presents long-term follow-up findings on antithrombotic management patterns in Asian patients with acute coronary syndrome from …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-06-12FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Limited. This action confirms approval of th…
-
FDA approval · 2014-06-12FDA Approved: HEPARIN SODIUM — Original Application (Sandoz Inc.)
FDA approved Sandoz Inc.'s original application for generic heparin sodium, an injectable anticoagulant used to prevent and treat thrombotic…
-
FDA approval · 2014-06-11FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application to authorize a generic clopidogrel bisulfate product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome [Phase 3]
Phase 3 trial of rivaroxaban in patients with acute coronary syndrome has completed; results outlining efficacy and safety have been posted.
-
FDA approval · 2014-05-29FDA Approved: HEPARIN SODIUM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Heparin Sodium (Hospira, Inc.), updating the approved generic product under the ANDA program.
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Usefulness of Chest Wall Tenderness as Bedside Test to Exclude Acute Coronary Syndrome in Different Demographic Groups
The completed trial evaluated whether chest wall tenderness can be used at the bedside to help exclude acute coronary syndrome across differ…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: T-Wave Alternans in Patients With Suspected Acute Coronary Syndrome
A completed clinical trial evaluating T-Wave Alternans in patients with suspected acute coronary syndrome.
-
CLINICAL_TRIALS withdrawal · 2014-05-26Clinical Trial Update: Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study [Phase 4]
A Phase 4 trial evaluating pretreatment with ticagrelor to reduce residual thrombus after PCI in patients with acute coronary syndrome has b…
-
CLINICAL_TRIALS research · 2014-05-13Clinical Trial Update: A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients With a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis
A completed retrospective Swedish cohort study examining health outcomes, life expectancy, resource use and costs in patients with a history…
-
EMA withdrawal · 2014-05-12EMA Lapsed: Clopidogrel Teva Generics B.V. (clopidogrel (as hydrochloride)) — Teva Pharma B.V.
EMA has lapsed the marketing authorization for Clopidogrel Teva Generics B.V. (clopidogrel as hydrochloride).
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography [Phase 3]
A Phase 3 multicenter trial evaluating whether cardiac computed tomography can rule out myocardial infarction in patients with suspected acu…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [Phase 3]
Phase 3 trial comparing ticagrelor (AZD6140) to clopidogrel in Asian/Japanese patients with non-ST- and ST-elevation acute coronary syndrome…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: A Clinical Trial to Demonstrate the Efficacy of Cangrelor [Phase 3]
A Phase 3 trial of cangrelor for myocardial infarction and acute coronary syndromes was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-04-22Clinical Trial Update: The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man [Phase 2]
A Phase 2 clinical trial evaluated the effects of clopidogrel and ticagrelor, with and without acetylsalicylic acid (ASA), on activation of …
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. [Phase 3]
A Phase 3 trial comparing cangrelor to standard therapy for platelet inhibition in patients with atherosclerosis and acute coronary syndrome…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome [Phase 3]
Phase 3 cardiovascular outcomes study of alogliptin in adults with type 2 diabetes and acute coronary syndrome has completed and results hav…
-
FDA approval · 2014-04-11FDA Approved: CLOPIDOGREL — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's original application for clopidogrel, enabling a generic version of the antiplatelet medicatio…
-
CLINICAL_TRIALS research · 2014-04-11Clinical Trial Update: Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS [Phase 2, Phase 3]
Clinical trial update on genotyping-guided, individualized treatment using clopidogrel or ticagrelor in acute coronary syndrome across Phase…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Maintenance of Platelet Inhibition With Cangrelor [Phase 2]
This document reports results from a Phase 2 trial evaluating maintenance of platelet inhibition with cangrelor in patients with acute coron…
-
CLINICAL_TRIALS research · 2014-04-02Clinical Trial Update: Determinants of Cognitive Impairment After Acute Coronary Syndrome
A completed clinical trial from University Hospital, Bordeaux examining determinants of cognitive impairment after an acute coronary syndrom…